Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Cremolini

Showing results (31-40 of 284) with videos related to

Pageof 29
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 13, 2023
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trialsDaniele Rossini, Alessandra Boccaccino, Martina Carullo, et al.
Lancet (London, England)|June 23, 2024
Colorectal cancerCathy Eng, Takayuki Yoshino, Erika Ruíz-García, et al.
Current Cancer Drug Targets|January 22, 2010
Targeting vascular endothelial growth factor pathway in first-line treatment of metastatic colorectal cancer: state-of-the-art and future perspectives in clinical and molecular selection of patientsFotios Loupakis, Guido Bocci, Giuseppe Pasqualetti, et al.
Oncology Letters|April 26, 2014
<i>KRAS</i> and <i>BRAF</i> genotyping of synchronous colorectal carcinomasRiccardo Giannini, Cristiana Lupi, Fotios Loupakis, et al.
Critical Reviews in Oncology/Hematology|June 20, 2015
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysisFilippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, et al.
Cancer Treatment Reviews|March 25, 2022
The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular featuresMarco Maria Germani, Beatrice Borelli, Piero Boraschi, et al.
Plos One|July 13, 2016
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research ActivitiesAnna Moretti, Michele Ghidini, Carmine De Angelis, et al.
Frontiers in Oncology|February 6, 2025
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinionCarmine Pinto, Sara Lonardi, Evaristo Maiello, et al.
Tumori|October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trialFilippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2013
Prevention and management of adverse events related to regorafenibMieke De Wit, Christine B Boers-Doets, Alessandra Saettini, et al.
Pageof 29

Showing results (31-40 of 284) with videos related to

Sort By:
Pageof 29
European Journal of Cancer (Oxford, England : 1990)|March 13, 2023
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trialsDaniele Rossini, Alessandra Boccaccino, Martina Carullo, et al.
Lancet (London, England)|June 23, 2024
Colorectal cancerCathy Eng, Takayuki Yoshino, Erika Ruíz-García, et al.
Current Cancer Drug Targets|January 22, 2010
Targeting vascular endothelial growth factor pathway in first-line treatment of metastatic colorectal cancer: state-of-the-art and future perspectives in clinical and molecular selection of patientsFotios Loupakis, Guido Bocci, Giuseppe Pasqualetti, et al.
Oncology Letters|April 26, 2014
<i>KRAS</i> and <i>BRAF</i> genotyping of synchronous colorectal carcinomasRiccardo Giannini, Cristiana Lupi, Fotios Loupakis, et al.
Critical Reviews in Oncology/Hematology|June 20, 2015
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysisFilippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, et al.
Cancer Treatment Reviews|March 25, 2022
The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular featuresMarco Maria Germani, Beatrice Borelli, Piero Boraschi, et al.
Plos One|July 13, 2016
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research ActivitiesAnna Moretti, Michele Ghidini, Carmine De Angelis, et al.
Frontiers in Oncology|February 6, 2025
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinionCarmine Pinto, Sara Lonardi, Evaristo Maiello, et al.
Tumori|October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trialFilippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2013
Prevention and management of adverse events related to regorafenibMieke De Wit, Christine B Boers-Doets, Alessandra Saettini, et al.
Pageof 29